Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

Russia's manufacturing activity contracted sharply in June, a sign that its economy could be slowing. The downturn was driven by weak demand and a strong ruble, affecting exports and jobs. Russia ...

The Switch 2’s System Transfer tool makes this a pretty simple process—but it can also be pretty hectic thanks to some improperly explained restrictions.

The Commercial Reserve Manufacturing Network would include dual-use manufacturing firms qualified to produce military systems when called upon.

Trump’s effort to bolster American manufacturing is unproductive.

GSK's NDA for linerixibat, for treating itch in PBC patients, gets FDA review with a decision due in March 2026.

British drugmaker GSK is preparing for potential new U.S. tariffs on its medicines and can handle the challenge, the company’s leader said Wednesday. “I would say we’ve been preparing, we ...

By Kelly Cloonan Shares of Spero Therapeutics gained after the company and GSK ended their trial for a treatment for complicated urinary tract infections early after it met its primary endpoint.

Despite some high-profile pledges to invest in domestic manufacturing, Wells Fargo doesn't see an increase in factory jobs in the foreseeable future.

GSK acquires Boston Pharmaceuticals' efimosfermin for up to $2 billion, targeting liver diseases like MASH and ALD.

GSK will acquire liver-disease treatment efimosfermin from Boston Pharmaceuticals for up to $2 billion to expand its portfolio. The British pharma giant said Wednesday that it will pay the U.S ...

Photo: chris j ratcliffe/Reuters GSK GSK -0.60% will acquire a liver-disease treatment from Boston Pharmaceuticals for up to $2 billion as it seeks to boost its pipeline of new drugs.